Loading...
OTCM
KLYG
Market cap2mUSD
Jul 10, Last price  
0.14USD
1D
0.00%
1Q
17.72%
Jan 2017
429.33%
IPO
-37.73%
Name

Kelyniam Global Inc

Chart & Performance

D1W1MN
OTCM:KLYG chart
P/E
P/S
0.59
EPS
Div Yield, %
Shrs. gr., 5y
17.39%
Rev. gr., 5y
3.98%
Revenues
3m
-8.27%
69,25046,5671,857,5161,748,4191,519,6291,526,1351,848,1042,123,6992,183,1252,512,1012,664,4343,017,5992,672,3573,328,3843,053,222
Net income
-139k
L-84.94%
-114,186-182,70114,936-4,772-39,963-13,512-72,538-15,304-357,953141,075201,741-97,560-218,471-920,206-138,555
CFO
-194k
L
28,357331056,30536,70911,797141,45015,002-239,294202,025124,297-31,753-95,773103,581-193,858

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers. Additionally, Kelyniam develops, produces, and supplies specific cranial and craniofacial fixation screws, crucial for the reconstruction of skull and facial structures. Its clientele encompasses health systems, hospitals, sales representatives, surgeons, insurance providers (payors), and individual patients. Established in 2005, the company was originally named Ketner Global Investments, Inc., rebranding to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Collinsville, Connecticut.
IPO date
Apr 03, 2008
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT